Category:Enzyme inhibitors
Jump to navigation
Jump to search
molecule that binds to an enzyme and decreases its activity | |||||
Upload media | |||||
Instance of |
| ||||
---|---|---|---|---|---|
Subclass of |
| ||||
Physically interacts with | |||||
| |||||
![]() |
Subcategories
This category has the following 24 subcategories, out of 24 total.
A
C
D
- Dabrafenib (7 F)
F
G
H
- Halicin (3 F)
I
K
- Kallikrein inhibitors (3 F)
- KRAS inhibitors (6 F)
L
- Levomilnacipran (5 F)
- Ligase inhibitors (1 F)
N
- 3-Nitrooxypropanol (2 F)
O
- Odanacatib (4 F)
S
T
- Targeted covalent inhibitors (5 F)
Media in category "Enzyme inhibitors"
The following 136 files are in this category, out of 136 total.
- 2OG Oxygenase Inhibitors.png 540 × 340; 13 KB
- 5evb.jpg 1,000 × 800; 324 KB
- AChe inhibitors pic.jpg 434 × 546; 74 KB
- Agonist Antagonist.png 428 × 249; 15 KB
- Agonist Antagonist.svg 800 × 460; 193 KB
- All inhibition types.png 613 × 383; 175 KB
- Avasimibe.svg 161 × 77; 11 KB
- BACE-1 Inhibitors (13328957395).png 1,046 × 1,115; 720 KB
- Binding sites enzyme inhibitors.svg 758 × 404; 15 KB
- Ceramidesynthasefb1.png 667 × 362; 27 KB
- Comp.jpg 298 × 276; 14 KB
- Competitive competition.png 1,765 × 1,020; 1.08 MB
- Competitive Image.jpg 1,478 × 838; 103 KB
- Competitive inhibition de.svg 820 × 575; 14 KB
- Competitive inhibition es.svg 820 × 575; 19 KB
- Competitive inhibition hi.svg 820 × 575; 14 KB
- Competitive inhibition id.svg 820 × 575; 16 KB
- Competitive inhibition int.svg 820 × 575; 19 KB
- Competitive inhibition-es.jpg 820 × 575; 115 KB
- Competitive inhibition.png 820 × 575; 47 KB
- Competitive inhibition.svg 820 × 575; 14 KB
- Competitive inhibitor diagram es.svg 134 × 284; 11 KB
- Competitive inhibitor diagram-1-.png 134 × 284; 10 KB
- Competitive inhibitor Fi.svg 134 × 284; 11 KB
- Competitive inhibitor-bn.svg 134 × 284; 16 KB
- Competitive inhibitor-ml.svg 179 × 379; 19 KB
- Competitive inhibitor-mr.svg 134 × 284; 16 KB
- Competitive inhibitor-ne.svg 134 × 284; 16 KB
- Competitive inhibitor-te.svg 134 × 284; 16 KB
- Competitive inhibitor.svg 134 × 284; 16 KB
- Competitiveinhibitor.jpg 362 × 291; 7 KB
- Complejo enzima-sustrato (llave-cerradura).jpg 794 × 303; 19 KB
- Covalent Drugs Timeline.png 3,096 × 2,070; 515 KB
- Covalent-drugs-silence-proteins.png 2,376 × 1,591; 479 KB
- CTP Inhibits ATCase.jpg 609 × 519; 27 KB
- DFMO inhibitor mechanism.svg 528 × 262; 38 KB
- DHFR methotrexate inhibitor 2.svg 1,179 × 1,132; 310 KB
- DHFR methotrexate inhibitor.png 914 × 861; 176 KB
- DHFR methotrexate inhibitor.svg 1,800 × 1,728; 310 KB
- Domain structure of mTOR.png 472 × 130; 9 KB
- End-Product Inhibition of Threonine to Isoleucine.png 1,537 × 778; 75 KB
- Enzymatic Inhibition by Succinate Accumulation.png 1,692 × 762; 153 KB
- Enzymatic inhibition by succinate accumulation.png 1,699 × 762; 153 KB
- Enzymatic inhibition by succinate.png 1,278 × 907; 114 KB
- Enzyme Inhibition lineweaver-burk plots.gif 710 × 280; 16 KB
- Enzyme inhibition plots and details from my lecture.png 2,388 × 1,624; 1.03 MB
- Enzyme inhibition schemes-es - esquemas de inhibicion enzimatica.png 600 × 854; 29 KB
- Enzyme inhibition schemes.png 600 × 854; 29 KB
- Enzyme inhibitor types.svg 517 × 165; 122 KB
- Enzyme inhibitor.svg 820 × 482; 361 KB
- Enzyme inhibitors 2.svg 1,771 × 1,141; 366 KB
- Enzyme inhibitors.svg 1,800 × 1,800; 56 KB
- Enzyme kinetics curve.png 765 × 515; 129 KB
- F3 Inhibitor.jpg 1,280 × 374; 45 KB
- Fig5 inhibitors.jpg 945 × 728; 158 KB
- Hong's mGlu4 PAM number 22A (2011) with tube model.png 907 × 536; 87 KB
- IDD594 protein-inhibitor complex.jpg 720 × 540; 53 KB
- Identification-of-Chalcones-as-Fasciola-hepatica-Cathepsin-L-Inhibitors-Using-a-Comprehensive-pntd.0004834.s009.ogv 1 min 12 s, 640 × 480; 832 KB
- Identification-of-Chalcones-as-Fasciola-hepatica-Cathepsin-L-Inhibitors-Using-a-Comprehensive-pntd.0004834.s010.ogv 1 min 9 s, 640 × 480; 403 KB
- Incopetititve inhibition-es.png 960 × 759; 58 KB
- Inhibicija.jpg 449 × 599; 28 KB
- Inhibició SDH.jpg 1,050 × 323; 90 KB
- Inhibidores de la PLpro.jpg 624 × 518; 52 KB
- Inhibiteur competitif.png 134 × 284; 12 KB
- Inhibition (zh-tw).png 614 × 854; 64 KB
- Inhibition diagrams es.png 257 × 600; 27 KB
- Inhibition diagrams tr.PNG 707 × 1,650; 64 KB
- Inhibition diagrams-1-.png 257 × 600; 34 KB
- Inhibition diagrams-1-gl.png 257 × 600; 29 KB
- Inhibition drawing.jpg 1,223 × 711; 128 KB
- Inhibition mechanism (irreversible).svg 1,300 × 1,300; 54 KB
- Inhibition mechanism (reversible).svg 1,300 × 3,000; 115 KB
- Inhibition schematic (irreversible).svg 496 × 1,276; 14 KB
- Inhibition schematic (reversible).svg 1,800 × 4,400; 90 KB
- Inhibition.png 640 × 854; 28 KB
- Inkretine und DPP-4-Iinhibitoren.svg 522 × 317; 30 KB
- Irreversible inactivation2.svg 467 × 364; 20 KB
- Irreversible Inhibition.png 784 × 146; 9 KB
- JAK3 inhibitors and ATP LOKA.png 692 × 1,116; 108 KB
- JAK3 inhibitors ATP.png 664 × 1,102; 148 KB
- JanusKinas3-WIKI.png 898 × 1,436; 150 KB
- Kompetitive Inhibition von Enzymen.svg 134 × 284; 16 KB
- Kompetitivna inhibicija.jpg 800 × 561; 52 KB
- Kynapcin-24.svg 1,317 × 796; 4 KB
- LindaInhibitors.jpg 902 × 269; 27 KB
- Lineweaver-Burke plot competitive inhibition.svg 514 × 283; 35 KB
- Lineweaver-Burke plot non-competitive inhibition.svg 514 × 283; 37 KB
- Michaelis-Menten Inhibitions.png 1,622 × 1,156; 68 KB
- Michaelis-Menten vs Substrate inhibited.png 1,659 × 1,323; 156 KB
- Monod vs Substrate inhibited.png 1,612 × 1,302; 154 KB
- N-(4-(2,4-Dihydroxyphenyl)thiazol-2-yl)isobutyramid.svg 513 × 293; 23 KB
- Nagstatin.svg 525 × 480; 15 KB
- Non competitive-inhibition-es.jpg 795 × 534; 111 KB
- Non-competitive inhibition.svg 879 × 983; 31 KB
- Noncomp.jpg 302 × 212; 15 KB
- Noncompetitive inhibition.png 299 × 201; 2 KB
- Nonsteroidal derivatives.png 432 × 151; 16 KB
- Oteracil skeletal.svg 160 × 138; 7 KB
- Overview reversible enzyme inhibitors-DE.svg 1,772 × 744; 8 KB
- PDB 1GXF.png 2,559 × 1,855; 1.47 MB
- Pevonedistat.svg 201 × 156; 18 KB
- PF-4800567 structure.png 422 × 514; 21 KB
- PLX4032 BRAF inhibitor.png 1,619 × 952; 22 KB
- Polyozellin.svg 1,697 × 1,120; 4 KB
- Potato CPA inhibitor ribbon.jpg 1,200 × 900; 405 KB
- Progeria20132-300.jpg 4,290 × 2,133; 1.07 MB
- Progeria37-72.jpg 500 × 523; 30 KB
- RB-101.png 254 × 313; 5 KB
- RBN-2397.svg 609 × 305; 15 KB
- Reishi5alpha.jpg 334 × 249; 8 KB
- Renin inhibitor timeline..png 1,524 × 544; 120 KB
- Reversible inhibition.svg 761 × 361; 6 KB
- RG7834.png 1,778 × 982; 73 KB
- RI-1.svg 512 × 284; 7 KB
- RibonucleaseA Uvan inhibitor contacts 1ruv.jpg 610 × 768; 226 KB
- Rigosertib.svg 512 × 158; 15 KB
- SekPlot2.png 851 × 623; 52 KB
- Sphingolipid metabolism.png 852 × 575; 143 KB
- Suicideinhibition.png 480 × 386; 7 KB
- TGDDF-GDDF.svg 328 × 216; 34 KB
- Tsou plot for pepsin inactivation.pdf 1,491 × 1,300; 113 KB
- Types of inhibition de.svg 678 × 876; 24 KB
- Typy inhibicji.svg 1,120 × 1,866; 192 KB
- Uncomp.jpg 295 × 217; 16 KB
- Uncompetitive inhibition.png 2,444 × 1,564; 25 KB
- VNI molecule.svg 512 × 235; 31 KB
- Wykres L-B dla inhibicji kompetycyjnej.svg 570 × 380; 81 KB
- Wykres L-B dla inhibicji niekompetycyjnej.svg 570 × 380; 43 KB